Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| 52 North Health | 2025 | Grant | Undisclosed | Cambridge |
| Solasta Bio | 2024 | Series A | Undisclosed | Glasgow |
| MIRICO | 2025 | Non-equity Assistance | Undisclosed | Didcot |
| Forge Care | 2022 | Series A | Undisclosed | Nuneaton |
| iethico | 2023 | Convertible Note | Undisclosed | Harrogate |
| Orbit Discovery | 2021 | Seed | Undisclosed | Oxford |
| Linear Diagnostics | 2025 | Grant | Undisclosed | Birmingham |
| Learnerbly | 2023 | Series A | Undisclosed | London |
| Regent | 2024 | Venture - Series Unknown | Undisclosed | North Kingstown |
| Quantum Dice | 2025 | Grant | Undisclosed | Oxford |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | 52 North Health | Grant | Undisclosed | Cambridge, United Kingdom |
| 2 | Solasta Bio | Series A | Undisclosed | Glasgow, United Kingdom |
| 3 | MIRICO | Non-equity Assistance | Undisclosed | Didcot, United Kingdom |
| 4 | Forge Care | Series A | Undisclosed | Nuneaton, United Kingdom |
| 5 | iethico | Convertible Note | Undisclosed | Harrogate, United Kingdom |
| 6 | Orbit Discovery | Seed | Undisclosed | Oxford, United Kingdom |
| 7 | Linear Diagnostics | Grant | Undisclosed | Birmingham, United Kingdom |
| 8 | Learnerbly | Series A | Undisclosed | London, United Kingdom |
| 9 | Regent | Venture - Series Unknown | Undisclosed | North Kingstown, United States |
| 10 | Quantum Dice | Grant | Undisclosed | Oxford, United Kingdom |
52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Transformational gas measurement
Forge Care is a provider of specialist residential care for children
AI powered drug shortage solutions for access to medicine
Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases.
Linear Diagnostics Limited is a diagnostics company based on a novel technology
Learnerbly is a Learning Development Platform.
Regent develops and manufactures all-electric seagliders for high-speed regional coastal transportation.
Quantum technology spin-out from the University of Oxford
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Geospatial Insight is a provider of independent research derived from the analysis of satellite imagery.
Silicon MicroGravity is a company developing novel sensor technology.
Zentraxa has specialise in the design, production and testing of complex novel peptides.
twig bio operates as a bioengineering startup.
Inductosense is developing wireless, battery-free, sensors that can be permanently fixed.
Vaarst develops robotic analytic solutions for marine applications.
Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.
Rovco provides an autonomous underwater vehicle and remotely operated underwater vehicle technologies and support services.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Nourished provides a customized nutrition product that uses patented 3D printing technology to create bespoke gummy vitamins on demand.
Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.
Industry 4.0, Edge, SaaS, AI, ML, Digital Twin, Faster to the Best Part First Time
Inicio AI is a SaaS platform that builds the conversational AI driven tool that helps in income and expenditure assessment.
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
Future Planet Capital has invested in 123 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Future Planet Capital's top investment sectors include Artificial Intelligence (AI), Health Care, Biotechnology, Manufacturing, Medical. The firm invests across 62 different industry categories.
Among tracked funding rounds, Tropic Biosciences received $105.0M in a Series C round. Future Planet Capital's total known invested capital is $818.8M.
Future Planet Capital's average investment size is $11.1M across its portfolio of 123 companies.
Recent Future Planet Capital portfolio additions include 52 North Health, Solasta Bio, MIRICO, Forge Care, iethico. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors